BCPS

Husson Nursing Program Celebrating 40 Years of Educating Tomorrow’s Health Professionals

Retrieved on: 
Monday, April 22, 2024
Education, School, Husson University, Silver, Hospital, Safety, Health, Humanities, Partnership, Doctor of Philosophy, BCPS, Sauda, Curriculum, Science, Doctor of Pharmacy, MPH, College, Faculty, Husson, Nurse education, Student, Nursing

BANGOR, MAINE, April 22, 2024 (GLOBE NEWSWIRE) -- Husson University’s School of Nursing is celebrating its 40th year of educating future healthcare professionals this year.

Key Points: 
  • BANGOR, MAINE, April 22, 2024 (GLOBE NEWSWIRE) -- Husson University’s School of Nursing is celebrating its 40th year of educating future healthcare professionals this year.
  • In 1983, then-Husson College matriculated its first class of students in the bachelors of science in nursing program.
  • “We’re thrilled to welcome back Husson nursing students and to share the rich history of our program and nursing in Maine.
  • Nursing teas are a tradition in Maine for celebrating nursing students and the nursing profession.

DoseMe Enables Precision Dosing at Independence Health System

Retrieved on: 
Thursday, May 2, 2024
Biotechnology, Technology, Professional Services, Health, Pharmaceutical, Health Technology, Medical Devices, Data Analytics, Software, Hospitals, Genetics, Pharmacogenomics, Palliative care, Hospital, Cardiology, Elective surgery, Partnership, BCPS, Patient, Record, Doctor of Pharmacy, Physician, AUC, Excela Health, Pharmacist, Pharmaceutical industry

DoseMe , a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System .

Key Points: 
  • DoseMe , a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System .
  • This alliance will advance therapeutic drug monitoring and optimize pharmacogenetics integration into pharmacokinetic/pharmacodynamic (PK/PD) models as part of IHS’s precision dosing strategy and initiatives.
  • With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties.
  • For more information on precision dosing models offered by DoseMe, visit https://doseme-rx.com/why-dosemerx/drug-packages

NCCN 2024 Annual Conference Shares Cancer Care Updates for Practical, Immediate Use in Practice

Retrieved on: 
Thursday, April 11, 2024
Maker, Congress, University, Cancer, NCCN, Risk, Policy, National Comprehensive Cancer Network, Hereditary nonpolyposis colorectal cancer, MD, Conference, BCPS, Research, University of Utah Hospital, Genetic testing, Patient, Doctor of Pharmacy, Physician, Caregiver, MBA, MHA, Pharmacist, Nursing

PLYMOUTH MEETING, Pa., April 11, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7. The yearly meeting includes opportunities for care providers to interact with world-renowned specialists on the latest evidence-based expert consensus recommendations for delivering high quality, patient-centered cancer care. Sessions focused on practical applications for improving care at every level, including clinical and administrative tracks, patient perspectives, and pressing policy issues.

Key Points: 
  • PLYMOUTH MEETING, Pa., April 11, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7.
  • It includes both the clinical and administrative aspects of cancer care delivery; practical things to apply immediately.
  • "Clinical practice guidelines and continuing education events such as NCCN's Annual Conference democratize care and disseminate knowledge.
  • Other sessions delved into the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for numerous cancer types, including:

Media Advisory: DoseMe Bioinformatician and Chief Science and Strategy Officer Co-Author Abstract Big Data Bayesian Truths to Be Covered in Oral Presentation at the 24th ECCMID Annual Meeting

Retrieved on: 
Tuesday, April 9, 2024
Biotechnology, Pharmaceutical, Health, Infectious Diseases, Hospitals, Health Technology, Genetics, Clinical Trials, Congress, Midwestern University, BCPS, Doctor of Pharmacy, Professor, AUC, Patient, Big data, Vancomycin, Safety, ESCMID, ECCMID, European, Infection, Pharmaceutical industry

ECCMID is the annual meeting of ESCMID, the European Society of Clinical Microbiology and Infectious Diseases, a registered non-profit organization in Basel, Switzerland.

Key Points: 
  • ECCMID is the annual meeting of ESCMID, the European Society of Clinical Microbiology and Infectious Diseases, a registered non-profit organization in Basel, Switzerland.
  • Abstract co-authored Dr. Sharmeen Roy, PharmD, BCPS , Chief Strategy and Science Officer and Paul Sabourenkov , Lead Bioinformatician at DoseMe.
  • What: Abstract 05305, Big Data Bayesian Truths: no vancomycin trough concentration target is sufficiently precise for safety or efficacy.
  • Details: Title: Big data Bayesian truths: no vancomycin trough concentration target is sufficiently precise for safety or efficacy.

Advanced Infliximab Model Now Available from DoseMe

Retrieved on: 
Friday, March 15, 2024
Technology, Research, Health Technology, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Inflammatory bowel disease, Risk, Infliximab, IBD, Patient, Immunoglobulin G, BCPS, Doctor of Pharmacy, Inflammation, Vaccine

DoseMe , a leading provider of model-informed precision dosing, today announced the availability of its Infliximab model.

Key Points: 
  • DoseMe , a leading provider of model-informed precision dosing, today announced the availability of its Infliximab model.
  • Infliximab (IFX) is a purified, recombinant DNA-derived chimeric IgG monoclonal antibody protein that contains both murine and human components that inhibit tumor necrosis factor-alpha(TNFα).
  • "We continue to enhance our models, and this model may predict infliximab concentration in patients with anti-drug antibodies,” added Roy.
  • “Both the learning set and validation set of this model had a large diversity in an indication of the patients, thus making this model especially equipped to dose infliximab for many indications.”
    For more information and an overview of all models currently available, visit https://doseme-rx.com/why-dosemerx/drug-packages

Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care

Retrieved on: 
Wednesday, April 3, 2024
Real-World Evidence, RN, Success, BP, RRMM, Doctor of Pharmacy, BCPS, Selinexor, Incidence, Partnership, Physician, Manufacturing, Bachelor of Pharmacy, DNP, Nursing, Prior authorization, Pharmacist, Roger Hawkins (drummer), CAPM, MPA, BSN, Therapy, RPH, Pharmacy, Outcome, Safety, Infrared spectroscopy correlation table, Best practice, FCS, PACS, OCN, Data, Metric, Health care

FORT MYERS, Fla., April 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) leaders and pharmacy experts will share insights and best practices in specialty pharmacy operations and dispensing that are contributing to positive patient outcomes at the NCODA 2024 Spring Forum in Dallas. The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.

Key Points: 
  • The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.
  • "Our Rx To Go team members continue to set the standard of excellence for medically-integrated oncology pharmacy and support services," said FCS President & Managing Physician Lucio Gordan, MD .
  • "They are well-equipped to contribute top-tier knowledge to help steer the future of oncology care."
  • NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.

PTCB Announces Strategic Partnership with PLEI to Launch Exclusive Leadership Institute for Pharmacy Technicians

Retrieved on: 
Thursday, February 22, 2024
BCPS, Pharmacy, Growth, PLEI, Doctor of Pharmacy, Vision, Leadership Institute, Health, Integrity, Partnership, Management

William Schimmel, PTCB's Executive Director & CEO, expressed excitement about this collaboration, stating, "This leadership institute is a testament to our commitment to advancing the pharmacy profession by investing in the growth and leadership potential of pharmacy technicians.

Key Points: 
  • William Schimmel, PTCB's Executive Director & CEO, expressed excitement about this collaboration, stating, "This leadership institute is a testament to our commitment to advancing the pharmacy profession by investing in the growth and leadership potential of pharmacy technicians.
  • The partnership with PLEI aligns with PTCB's dedication to fostering excellence in pharmacy practice.
  • Pharmacy technicians, through this program, will gain valuable insights and skills that are vital for career advancement.
  • "PLEI is thrilled to be in partnership with PTCB and eager to share this significant step forward in leader development for pharmacy technicians," said John Grabenstein, PLEI's Chairman of the Board.

HOPA and Cancer Support Community Bring Together Patient and Pharmacist Points of View

Retrieved on: 
Friday, February 16, 2024
BCPS, Pharmacy, Caregiver, Student, CST, Central Time Zone, Education, Research, Club, MSS, Doctor of Pharmacy, LSW, CPP, Ovarian cancer, HOPA, Patient, Knowledge, CSC, Interview, Cancer Support Community, Partnership, Nursing

MILWAUKEE, Feb. 16, 2024 /PRNewswire-PRWeb/ -- The virtual interview is part of the CSC series, "Frankly Speaking about Cancer" and takes place via Zoom on Tuesday, February 27 at 5 p.m. Central Standard Time.

Key Points: 
  • The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Cancer Support Community (CSC) for a live video interview with an oncology pharmacist and cancer patient.
  • The video interview will show the perspective of both the patient and pharmacist involved in cancer treatment and will highlight the role of oncology pharmacy.
  • The Cancer Support Community is a global nonprofit that uplifts and strengthens people impacted by cancer.
  • http://www.cancersupportcommunity.org
    The Hematology/Oncology Pharmacy Association (HOPA) supports hematology/oncology pharmacy professionals and promotes the role of the pharmacist in collaborative cancer care.

DoseMe Expands Vancomycin Hemodialysis Model

Retrieved on: 
Thursday, February 15, 2024
Technology, Health Technology, Software, Biotechnology, Health, Pharmaceutical, General Health, Data Management, Artificial Intelligence, BCPS, TDM, Toxicity, Obesity, HD, Dialysis, Vancomycin, Doctor of Pharmacy, Risk, Medicine, Patient, IHD, Medical device

DoseMe , a leading provider of model informed precision dosing, today announced the availability of its new Vancomycin Hemodialysis (HD) model.

Key Points: 
  • DoseMe , a leading provider of model informed precision dosing, today announced the availability of its new Vancomycin Hemodialysis (HD) model.
  • The vancomycin hemodialysis (HD) model enables personalized dosing that reduces the necessity for multiple blood draws for vancomycin levels.
  • Implementing this optimized model could further enhance precision and personalization of vancomycin therapy in hemodialysis patients.
  • Overall, integrating the optimized model with DoseMeRx has potential to improve vancomycin dosing accuracy and outcomes in the hemodialysis population.

Rita Case Wins Prestigious TIME Dealer of the Year Award

Retrieved on: 
Thursday, February 8, 2024
Professional Services, Philanthropy, General Automotive, Automotive, Small Business, Fund Raising, Other Transport, Foundation, Transport, Automotive Manufacturing, Other Automotive, Other Philanthropy, Manufacturing, HEART, Economics, Partnership, Holiday, Interim, Creativity, Timmerman, American Cancer Society, Woman, Federal Reserve Bank, Broward County Public Schools, Humanity, Nova Southeastern University, Cancer, Housing, Hyundai, Friends, Broward Health, BCPS, Cleveland Clinic, University of California, Davis, Boys & Girls Club, Ally Financial, Student, History, University, Sale, NADA, Organization, Trinity Health (Livonia, Michigan), TIME, Multimedia, American Heart Association, CPR, Community foundation, Acura, Boy, Female, National Automobile Dealers Association, Education, Freedom, Shoe, AHA, Baptist Health, Parent, Car dealership

Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.

Key Points: 
  • Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.
  • Rita is only the fifth woman to be named TIME Dealer of the Year.
  • TIME Dealer of the Year is the highest honor and most prestigious recognition an auto dealer can receive from the auto industry, and I am humbled and grateful for this award,” Rita said, as she received the award during the 107th Annual NADA Show in Las Vegas.
  • In 2023, the Community Foundation of Broward recognized Rita as a Community Builder and celebrated the establishment of the Rita & Rick Case Family Fund during a special ceremony.